Advertisement
Obstetrics/Gynecology
Subscribe to Obstetrics/Gynecology
View Sample

FREE Email Newsletter

OVA1 Included in Latest ACOG/SGO Committee Opinion

March 14, 2011 6:35 am | by Bio-Medicine.Org | News | Comments

AUSTIN, Texas, March 14, 2011 /- (Nasdaq: VRML ) –Vermillion, a molecular diagnostics company, announced today the inclusion of OVA1® as part of the recently published ACOG/SGO committee opinion. In the March edition of Obstetrics and Gynecology , the American College of...

K-V Pharmaceutical Company Announces Comprehensive Patient Assistance Program for Makenaâ„¢

March 8, 2011 7:34 am | by Bio-Medicine.Org | News | Comments

ST. LOUIS, March 8, 2011 /- K-V Pharmaceutical Company (NYSE: KVa/KVb) (the "Company"), a specialty pharmaceutical company, along with its branded subsidiary, Ther-Rx Corporation, today announced the details of its patient assistance program for Makena ™ -eligible patients....

FDA Approves Makenaâ„¢, the First and Only Treatment to Reduce the Risk of Preterm Birth in Women With a Singleton Pregnancy Who Have a History of Singleton Spontaneous Preterm ...

February 4, 2011 4:33 am | by Bio-Medicine.Org | News | Comments

ST. LOUIS, Feb. 4, 2011 /- K-V Pharmaceutical Company (NYSE: KVa/KVb) (the "Company"), a specialty pharmaceutical company, announced today that it has been informed by Hologic, Inc. that the U.S. Food and Drug Administration (FDA) granted approval for Makena™ (hydroxyprogesterone...

Advertisement

FDA Approves Drug to Reduce Risk of Preterm Birth in At-Risk Pregnant Women

February 4, 2011 4:33 am | by Bio-Medicine.Org | News | Comments

SILVER SPRING, Md., Feb. 4, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Makena (hydroxyprogesterone caproate) injection to reduce the risk of preterm delivery before 37 weeks of pregnancy, in pregnant women with a history of at least one...

FDA Approves Hologic's Makenaâ„¢ (Formerly Referred to as Gestivaâ„¢) Pharmaceutical

February 4, 2011 4:33 am | by Bio-Medicine.Org | News | Comments

BEDFORD, Mass., Feb. 4, 2011 /- Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX ), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, announced today the...

VIVUS Provides Regulatory Update on QNEXA NDA

January 21, 2011 3:36 am | by Bio-Medicine.Org | News | Comments

MOUNTAIN VIEW, Calif., Jan. 21, 2011 /- VIVUS, Inc. (Nasdaq: VVUS ) today announced that it held an End-of-Review meeting with the Food and Drug Administration (FDA) for the New Drug Application (NDA) for QNEXA®, an investigational drug for the treatment of obesity.  The meeting...

Accuray Hires Chief Marketing Officer

January 18, 2011 5:39 am | by Bio-Medicine.Org | News | Comments

SUNNYVALE, Calif., Jan. 18, 2011 /- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced today that Eric Pauwels has joined Accuray as Senior Vice President and Chief Marketing Officer, effective January 17, 2011. Pauwels is a global industry...

Reportlinker Adds Germany Pharmaceutical Market Overview - New pricing rules set to negatively impact drug sales both domestically and internationally

January 11, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Jan. 11, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Germany Pharmaceutical Market Overview – New pricing rules set to negatively impact drug sales both domestically and internationally...

Advertisement

Reportlinker Adds France Pharmaceutical Market Overview - Austerity measures will impact pharmaceutical market growth

January 11, 2011 5:34 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Jan. 11, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: France Pharmaceutical Market Overview – Austerity measures will impact pharmaceutical market growth...

Decades-Long Medical Study Begins With Kickoff

January 10, 2011 10:35 pm | by San Diego Business Journal | News | Comments

The San Diego County component of the nation's largest long-term examination of children's health and development was launched Jan. 10.

Sharp and Kaiser Are Putting Big Construction Plans Into Action

January 9, 2011 10:35 pm | by San Diego Business Journal | News | Comments

Construction projects planned by two local health care systems are promising to bring a major economic stimulus jolt to the San Diego region this year.

Viveve Obtains CE Mark for Gynecologic Treatment of Vaginal Laxity

January 6, 2011 3:35 am | by Bio-Medicine.Org | News | Comments

PALO ALTO, Calif., Jan. 6, 2011 /- Viveve, Inc. , a development stage women's health company, announced today that it has received the European CE (Conformite Europeenne) mark for the use of its Viveve System for the non-surgical treatment of laxity of the vaginal introitus (opening),...

Sequenom CMM Commences Pivotal Clinical Validation Study for Its SensiGene Trisomy 21 Laboratory Developed Test(2)

December 22, 2010 5:34 pm | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Dec. 22, 2010 /- Sequenom, Inc. (Nasdaq: SQNM ) today announced that the company's wholly-owned reference laboratory, the Sequenom Center for Molecular Medicine (Sequenom CMM), has authorized commencement of a pivotal clinical validation study. This validation study is designed...

Advertisement

Investors eye shift in Boston life sciences funding

December 21, 2010 7:35 pm | by Mass High Tech: The Journal of New England Technology | News | Comments

Venture capital may be playing a less important role in the region's biotech industry, while big pharma may be playing as important a role as VC, as a strategic investor to fund drug development, and as an eventual acquirer. Investors also point to more Boston-area activity by big pharma...

INVO Bioscience Announces First Shipments of INVOcell Into Bolivia

December 21, 2010 4:32 am | by Bio-Medicine.Org | News | Comments

BEVERLY, Mass., Dec. 21, 2010 /- INVO Bioscience, Inc. (OTC Bulletin Board: IVOB ), a medical device company focused on treatment options for patients diagnosed with infertility, today announced the initial shipments of the INVOcell device into Bolivia.  The initial order of INVOcell...

Stem Cells Made with RNA

December 20, 2010 8:34 pm | by Massachusetts Institute of Technology | News | Comments

A new technique could provide safer cells for human therapies

WomanCare Global Highlights the Unmet Need of 215 Million Women on Famous CBS Super Screen in Times Square

December 15, 2010 10:35 am | by Bio-Medicine.Org | News | Comments

CHAPEL HILL, N.C., Dec. 15, 2010 /PRNewswire-USNewswire/ -- WomanCare Global is pleased to announce that it is running an advertisement on the famous CBS Super Screen in New York's Times Square.  The purpose of the advertisement is to call attention to the estimated 215 million women...

Reportlinker Adds Corporate Strategies in Consumer Health 2010

December 14, 2010 9:35 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Dec, 14, 2010 /- Reportlinker.com announces that a new market research report is available in its catalogue: Corporate Strategies in Consumer Health 2010 http://www.reportlinker.com/p0338740/Corporate-Strategies-in-Consumer-Health-2010.html The consumer health market enjoyed...

Encision's Active Electrode Monitoring Technology Recommended at Minimally Invasive Gynecology Congress

November 17, 2010 7:36 am | by Bio-Medicine.Org | News | Comments

BOULDER, Colo., Nov. 17, 2010 /- Active electrode monitoring developed and manufactured by Boulder-based Encision Inc. (Pink Sheets: ECIA ), is the only monopolar energy technology proposed as a solution to eliminate visceral burns during Single Port Laparoscopy according to a recent...

Duncan Cancer Center researchers bring in more than $8 million in fourth round of state cancer funding

November 8, 2010 1:37 pm | by Baylor College of Medicine | News | Comments

Researchers from the NCI-designated Dan L. Duncan Cancer Center at Baylor College of Medicine have been awarded 11 new research projects totaling more than $8 million in the fourth round of recently awarded Cancer Prevention Research Institute of Texas grants. In this round, the...

National Quality Forum Members Elect New Council Leaders

November 1, 2010 11:37 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, Nov. 1, 2010 /PRNewswire-USNewswire/ -- The National Quality Forum (NQF) announces the election of leadership for four of its eight member councils.   NQF is a unique, multi-stakeholder, nonprofit organization dedicated to improving the quality of American healthcare by...

NIH Renews Georgia Tech-led Nanomedicine Center for $16.1 Million

October 28, 2010 8:33 am | by Georgia Tech Institute of Technology | News | Comments

The Nanomedicine Center for Nucleoprotein Machines has received $16.1 million as part of its renewal by the National Institutes of Health (NIH). The center will pursue development of a clinically viable gene correction technology for single-gene disorders.

Samplify's New Medical Ultrasound Development Kit Accelerates Equipment Time to Market By Up to 12 Months

October 27, 2010 10:34 am | by Bio-Medicine.Org | News | Comments

SANTA CLARA, Calif., Oct. 27 /- Samplify Systems, Inc., a leading provider of innovative beamforming technology, analog-front-end semiconductors and solutions for the medical imaging market, today introduces its new SMK9130 Ultrasound Beamforming Development Kit.  Based on Samplify's...

Inspiration Biopharmaceuticals' OBI-1 Receives Orphan Drug Designation in Europe

October 19, 2010 9:32 am | by Bio-Medicine.Org | News | Comments

LAGUNA NIGUEL, Calif., Oct. 19 /- Inspiration Biopharmaceuticals, Inc. (Inspiration) announced today that the European Commission has granted orphan drug status for OBI-1 for the treatment of hemophilia.  Expected to enter pivotal clinical trials before the end of this year, OBI-1 is...

Professional Liability Costs for Hospitals and Physicians Continue to Rise, Outpacing Inflation

October 12, 2010 9:31 am | by Bio-Medicine.Org | News | Comments

CHICAGO, Oct. 12 /- Hospitals and physicians should prepare for increasing liability costs , according to the 2010 Hospital Professional Liability and Physician Liability Benchmark Analysis created by Aon Risk Solutions , the global risk management business of Aon Corporation (NYSE: AON...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading